Course Provider
TheraPsil is a Canadian nonprofit advancing safe, equitable access to psychedelic-assisted therapy through clinician training, patient advocacy, legal reform, community education, and collaborative research. Founded in 2019, the organization supports psilocybin and MDMA care pathways in Canada while training healthcare professionals and related practitioners for legal, ethical psychedelic-assisted practice.
TheraPsil looks like a serious, advocacy-rooted Canadian training provider rather than a glossy school. Its strongest suit is practical, clinician-facing education tied to real access pathways, with a clear emphasis on ethics, patient-centred care, and the Canadian regulatory context. It appears best for licensed practitioners who want to work within legal psychedelic care, especially in psilocybin, rather than for curious laypeople or purely experiential seekers. Notable lineage includes Canada-based clinical and advocacy leadership, and its faculty are presented as experienced psychedelic psychotherapy and palliative care practitioners.
Best for licensed clinicians and prescribers who want structured training in legal psychedelic-assisted care, particularly in psilocybin and MDMA. It also seems suitable for allied professionals already working in mental health or healthcare who need credible continuing education and practice-ready protocols.
Varies by programme. Prescriber training is for licensed prescribing professionals such as physicians, psychiatrists, nurse practitioners, and equivalent roles. The broader psychotherapy trainings are aimed at healthcare professionals and professionals preparing to work in psychedelic-assisted care; some advanced or experiential routes appear to prefer prior psychedelic training or completion of foundational psilocybin training.
TheraPsil states its Psilocybin Prescriber Training is certified for 8 Mainpro+ CME credits. It also states its Fundamentals of Psilocybin Training Program has CPA and CCPA approval for 144.5 continuing education credit hours, and OPQ approval for 30 continuing education credit hours, with the site elsewhere also describing 155 CE hours for the psilocybin fundamentals pathway. TheraPsil notes that it tracks progress but the learner is responsible for applying for CE credit where relevant.
Prescriber Training is listed at $350 CAD plus tax, with TheraPsil membership required at $400 per year or $40 per month, making the first-year total $750 plus tax. The broader fundamentals pathways are listed at $3,600 CAD online or $4,450 CAD in person for psilocybin, and $3,600 CAD online or $4,999 CAD for MDMA didactic plus experiential options. Some supervision, experiential sessions, and onboarding or directory fees are separate, and payment plans and bursaries are available for most programmes.
Learners appear to leave with practice-oriented competencies in screening, intake, dosing, risk management, integration, multidisciplinary coordination, and navigation of Canadian access pathways. Depending on the programme, they may also gain a certificate of completion, CME or CE credit eligibility, and listing or affiliation in TheraPsil’s public practitioner directory or network.
Linked Courses
9
Active Listings
0
Primary Formats
Hybrid
Programs linked directly to this provider in the Blossom course dataset.
By Therapsil
This page summarizes Health Canada’s first known Special Access Program authorization for psilocybin, issued to support treatment for six patients experiencing end-of-life distress. It describes the SAP request process, the clinicians involved, and the supply and legal support used.
By Therapsil
Online prescriber education for regulated clinicians covering screening, clinical considerations, prescribing fundamentals, medication interactions, contraindications, risk management, treatment-team coordination, and Canadian access pathways.
Source lists: 8 hours
Delivery: Online + Canada
No medicine self-experience listed
By Therapsil
TheraPsil announced an MDMA-Assisted Psychotherapy Training Program for healthcare professionals. The pilot phase was expected to begin in early 2024 and to build on completion of TheraPsil’s Fundamentals of Psilocybin-Assisted Psychotherapy training.
By Therapsil
TheraPsil's professional training pathway prepares healthcare professionals and related practitioners for legal, ethical psychedelic-assisted care through didactic learning, live seminars, experiential components, and practicum-oriented training.
Source lists: 146 hours
Delivery: Online + Victoria, Montreal, London, Canada + Canada
Course options
Fundamentals
Standard on-demand access
Full Programme
Standard on-demand access
Fundamentals
Standard on-demand access
Advanced
Standard on-demand access
Full Programme
Standard on-demand access
New Mexico Track
Standard on-demand access
By Therapsil
TheraPsil’s Upcoming Fundamentals Training page lists open cohorts for psilocybin and MDMA fundamentals training, including online and in-person options. It provides cohort-specific details such as facilitators, tuition or early-bird pricing where available, and language options.
By Therapsil
This page presents TheraPsil’s case for allowing healthcare professionals approved to conduct psychedelic treatment to have first-hand psilocybin experience as part of professional training. It includes a letter of support from Charles S. Grob, M.D. and background on TheraPsil’s training efforts.
By Therapsil
Professional training from TheraPsil for regulated healthcare professionals interested in psychedelic-assisted care. Training is offered online or in person and is grounded in human-centred, evidence-informed practice.
Source lists: 144.5 hours
Delivery: Online + Canada
Includes medicine self-experience
By Therapsil
A collection of letters of support from healthcare professionals, researchers, and experts regarding legal access to psilocybin for healthcare professional training. The page explains the need for experiential training in psilocybin-assisted psychotherapy and the exemption process referenced by TheraPsil.
By Therapsil
TheraPsil’s page presents a letter from Paul Grof, MD, FRCPC supporting healthcare practitioner access to psilocybin for professional training. It explains the need for trained clinicians in psilocybin-assisted psychotherapy and the role of experiential learning in that training model.
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.